Folic acid supplementation in end-stage renal disease patients reduces total mortality rate.

Conclusions: In adult hemodialysis patients, folic acid supplementation improves cardiovascular and all-cause mortality rates.
PMID: 24052465 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)